EU Lists Rare Nerve Disorder as Side Effect of J&J COVID-19 Vaccine

By Reuters Staff

July 23, 2021

(Reuters) - Europe's medicines regulator said on Thursday it had added a nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson's COVID-19 vaccine after it reviewed 108 cases reported worldwide.

"After assessing the available data, PRAC considered that a causal relationship between COVID-19 vaccine Janssen and GBS is possible," the European Medicines Agency said, referring to its safety committee, PRAC.

The U.S. Food and Drug Administration last week also added a warning related to Guillain-Barre Syndrome to the J&J vaccine.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....